Background: There is a growing recognition that genetic predisposition contributes to the development of fibrotic ...
Background Emerging evidence suggests that lung function decline may be linked to cardiovascular disease (CVD), but this has ...
Background This study sought to describe the prevalence of lung hyperinflation in adults (≥18 years) with cystic fibrosis (awCF) and the effects of elexacaftor-tezacaftor-ivacaftor (ETI) on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results